Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222.

Teixeira AL, Gomes M, Medeiros R.

Front Genet. 2012 Dec 7;3:286. doi: 10.3389/fgene.2012.00286. eCollection 2012.

2.

A miRNA signature of prion induced neurodegeneration.

Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA.

PLoS One. 2008;3(11):e3652. doi: 10.1371/journal.pone.0003652. Epub 2008 Nov 6.

3.

EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW.

Cancer Res. 2010 Nov 1;70(21):8822-31. doi: 10.1158/0008-5472.CAN-10-0638. Epub 2010 Oct 26.

4.

Expression patterns of microRNAs associated with CML phases and their disease related targets.

Machová Poláková K, Lopotová T, Klamová H, Burda P, Trněný M, Stopka T, Moravcová J.

Mol Cancer. 2011 Apr 18;10:41. doi: 10.1186/1476-4598-10-41.

5.

Isolation of miRNAs that target EGFR mRNA in human lung cancer.

Yamaguchi G, Takanashi M, Tanaka M, Fujita K, Ohira T, Kuroda M, Ikeda N.

Biochem Biophys Res Commun. 2012 Apr 6;420(2):411-6. doi: 10.1016/j.bbrc.2012.03.008. Epub 2012 Mar 9.

PMID:
22426479
6.

Modeling of miRNA and drug action in the EGFR signaling pathway.

Li J, Pandey V, Kessler T, Lehrach H, Wierling C.

PLoS One. 2012;7(1):e30140. doi: 10.1371/journal.pone.0030140. Epub 2012 Jan 11.

7.

MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer.

Zhong M, Ma X, Sun C, Chen L.

Chem Biol Interact. 2010 Mar 30;184(3):431-8. doi: 10.1016/j.cbi.2010.01.025. Epub 2010 Jan 25.

PMID:
20097187
8.

Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7.

Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ.

J Biol Chem. 2009 Feb 27;284(9):5731-41. doi: 10.1074/jbc.M804280200. Epub 2008 Dec 10.

9.

A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway.

Qin L, Chen Y, Niu Y, Chen W, Wang Q, Xiao S, Li A, Xie Y, Li J, Zhao X, He Z, Mo D.

BMC Genomics. 2010 May 23;11:320. doi: 10.1186/1471-2164-11-320.

10.

miR-126 and miR-126*: new players in cancer.

Meister J, Schmidt MH.

ScientificWorldJournal. 2010 Oct 12;10:2090-100. doi: 10.1100/tsw.2010.198. Review.

11.

MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.

Aydoğdu E, Katchy A, Tsouko E, Lin CY, Haldosén LA, Helguero L, Williams C.

Carcinogenesis. 2012 Aug;33(8):1502-11. doi: 10.1093/carcin/bgs161. Epub 2012 May 4.

PMID:
22562546
12.

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.

Hummel R, Hussey DJ, Haier J.

Eur J Cancer. 2010 Jan;46(2):298-311. doi: 10.1016/j.ejca.2009.10.027. Epub 2009 Nov 28. Review.

PMID:
19948396
13.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

14.

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.

Rokah OH, Granot G, Ovcharenko A, Modai S, Pasmanik-Chor M, Toren A, Shomron N, Shpilberg O.

PLoS One. 2012;7(4):e35501. doi: 10.1371/journal.pone.0035501. Epub 2012 Apr 12.

15.

Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells.

Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP.

Mol Cancer. 2011 May 18;10:58. doi: 10.1186/1476-4598-10-58.

16.

MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.

Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L.

J Biol Chem. 2010 Dec 10;285(50):39551-63. doi: 10.1074/jbc.M110.114736. Epub 2010 Oct 4.

17.

MicroRNAs in cancers and neurodegenerative disorders.

Saito Y, Saito H.

Front Genet. 2012 Sep 26;3:194. doi: 10.3389/fgene.2012.00194. eCollection 2012.

18.

microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.

Lee KM, Choi EJ, Kim IA.

Radiother Oncol. 2011 Oct;101(1):171-6. doi: 10.1016/j.radonc.2011.05.050. Epub 2011 Jun 14.

PMID:
21676478
19.

Role of microRNAs in vascular diseases, inflammation, and angiogenesis.

Urbich C, Kuehbacher A, Dimmeler S.

Cardiovasc Res. 2008 Sep 1;79(4):581-8. doi: 10.1093/cvr/cvn156. Epub 2008 Jun 11. Review.

PMID:
18550634
20.

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.

Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y.

Eur J Cancer. 2010 Jun;46(9):1692-702. doi: 10.1016/j.ejca.2010.02.043. Epub 2010 Apr 3.

PMID:
20371173

Supplemental Content

Support Center